Palatin Technologies, Inc. (AMEX:PTN)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.

Featured Broker Partners


Advertisement